NUS Valuation

NU Skin Enterprises Inc

Add to Watchlist

Advanced Chart

10.720

+0.1(0.942%)1D

NUS Relative Valuation

NUS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NUS is overvalued; if below, it's undervalued.

Historical Valuation

NU Skin Enterprises Inc (NUS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 7.94 is considered Undervalued compared with the five-year average of 12.43. The fair price of NU Skin Enterprises Inc (NUS) is between 11.77 to 21.41 according to relative valuation methord. Compared to the current price of 10.72 USD , NU Skin Enterprises Inc is Undervalued By 8.96%.

Relative Value

Fair Zone

11.77-21.41

Current Price：10.72

8.96%

Undervalued

7.94

Trailing

Forward

0.00

EV/EBITDA

NU Skin Enterprises Inc. (NUS) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 6.38. The thresholds are as follows: Strongly Undervalued below 1.11, Undervalued between 1.11 and 3.75, Fairly Valued between 9.02 and 3.75, Overvalued between 9.02 and 11.65, and Strongly Overvalued above 11.65. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

5.70

EV/EBIT

NU Skin Enterprises Inc. (NUS) has a current EV/EBIT of 5.70. The 5-year average EV/EBIT is 9.94. The thresholds are as follows: Strongly Undervalued below 4.38, Undervalued between 4.38 and 7.16, Fairly Valued between 12.71 and 7.16, Overvalued between 12.71 and 15.49, and Strongly Overvalued above 15.49. The current Forward EV/EBIT of 5.70 falls within the Undervalued range.

10.72

NU Skin Enterprises Inc. (NUS) has a current PS of 10.72. The 5-year average PS is 0.71. The thresholds are as follows: Strongly Undervalued below -0.74, Undervalued between -0.74 and -0.01, Fairly Valued between 1.43 and -0.01, Overvalued between 1.43 and 2.15, and Strongly Overvalued above 2.15. The current Forward PS of 10.72 falls within the Strongly Overvalued range.

0.00

P/OCF

NU Skin Enterprises Inc. (NUS) has a current P/OCF of 0.00. The 5-year average P/OCF is 8.42. The thresholds are as follows: Strongly Undervalued below -2.22, Undervalued between -2.22 and 3.10, Fairly Valued between 13.74 and 3.10, Overvalued between 13.74 and 19.06, and Strongly Overvalued above 19.06. The current Forward P/OCF of 0.00 falls within the Undervalued range.

0.00

P/FCF

NU Skin Enterprises Inc. (NUS) has a current P/FCF of 0.00. The 5-year average P/FCF is 18.86. The thresholds are as follows: Strongly Undervalued below -11.49, Undervalued between -11.49 and 3.69, Fairly Valued between 34.03 and 3.69, Overvalued between 34.03 and 49.21, and Strongly Overvalued above 49.21. The current Forward P/FCF of 0.00 falls within the Undervalued range.

NU Skin Enterprises Inc (NUS) has a current Price-to-Book (P/B) ratio of 0.67. Compared to its 3-year average P/B ratio of 1.10 , the current P/B ratio is approximately -39.02% higher. Relative to its 5-year average P/B ratio of 1.76, the current P/B ratio is about -61.69% higher. NU Skin Enterprises Inc (NUS) has a Forward Free Cash Flow (FCF) yield of approximately 0.11%. Compared to its 3-year average FCF yield of 11.76%, the current FCF yield is approximately -99.06% lower. Relative to its 5-year average FCF yield of 9.60% , the current FCF yield is about -98.85% lower.

0.67

P/B

Median3y

1.10

Median5y

1.76

0.11

FCF Yield

Median3y

11.76

Median5y

9.60

Competitors Valuation Multiple

The average P/S ratio for NUS's competitors is 14.46, providing a benchmark for relative valuation. NU Skin Enterprises Inc Corp (NUS) exhibits a P/S ratio of 10.72, which is -25.87% above the industry average. Given its robust revenue growth of -12.06%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

NUS.N

NU Skin Enterprises Inc

Edgewell Personal Care Co

19.39

-3.18%

900.94M

Performance Decomposition

Market capitalization of NUS increased by 48.02% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 1.88 to 5.28.

The secondary factor is the Revenue Growth, contributed -12.06%to the performance.

Overall, the performance of NUS in the past 1 year is driven by P/E Change. Which is more unsustainable.

-12.06%

439.08M → 386.14M

Revenue Growth

-120.31%

-26.93 → 5.47

Margin Expansion

180.39%

1.88 → 5.28

P/E Change

48.02%